Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Graft versus host disease

L Y Matsuoka

    Journal of the American Academy of Dermatology
    |November 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Graft versus host disease (GVHD) affects bone marrow transplant recipients and can manifest in the skin. Diagnosis is confirmed via skin biopsy, highlighting the need for early detection and management strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Malignant melanoma.

    Archives of pathology & laboratory medicine·2001
    Same author

    Decreased bioavailability of vitamin D in obesity.

    The American journal of clinical nutrition·2000
    Same author

    Immunological responses to ultraviolet light B radiation in Black individuals.

    Life sciences·1999
    Same author

    Regular use of sunscreen on vitamin D levels.

    Archives of dermatology·1995
    Same author

    Compensation for the interracial variance in the cutaneous synthesis of vitamin D.

    The Journal of laboratory and clinical medicine·1995
    Same author

    Neoplastic erythema nodosum.

    Journal of the American Academy of Dermatology·1995
    Same journal

    Sexual function is missing from the adverse-effect map of GLP-1 receptor agonists in dermatology.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicenter cohort study.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Safety of Biologic Therapy in Psoriasis Patients With Malignancy.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Letter from the Editor: Glucagon-Like Peptide-1 (GLP-1) agonists in dermatology.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Rethinking the Occipital Scalp as a Control in Advanced Androgenetic Alopecia.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Parallel-Polarized Dermoscopy for Acral Parallel Pattern Analysis.

    Journal of the American Academy of Dermatology·2026
    See all related articles

    Area of Science:

    • Immunology
    • Hematology
    • Dermatology

    Background:

    • Graft versus host disease (GVHD) affects 50-70% of bone marrow transplant patients.
    • It can also occur in immunosuppressed patients receiving blood transfusions.
    • GVHD is primarily cell-mediated, with potential humoral factor involvement.

    Purpose of the Study:

    • To summarize the key aspects of Graft versus host disease.
    • To highlight the clinical manifestations and diagnostic methods for GVHD.

    Main Methods:

    • Review of existing literature on Graft versus host disease.
    • Analysis of clinical presentations and pathological findings.
    • Emphasis on diagnostic criteria, including skin biopsy.

    Main Results:

    Related Experiment Videos

    • Cutaneous manifestations are the earliest and most frequent signs of GVHD.
    • Lesions can present as morbilliform, scarlantiniform, lichenoid, or sclerodermoid.
    • Acute GVHD commonly affects skin, GI tract, and liver; chronic GVHD resembles collagen vascular disorders.

    Conclusions:

    • Skin biopsy is crucial for diagnosing Graft versus host disease.
    • Understanding GVHD's varied presentations is essential for patient management.
    • Early recognition of cutaneous signs aids in timely intervention.